Fig. 2From: One day versus two days of hepatic arterial infusion with oxaliplatin and fluorouracil for patients with unresectable hepatocellular carcinomaKaplan–Meier curves of overall survival (A), progression-free survival (B), overall survival for the PSM cohort (C), and progression-free survival for the PSM cohort (D). CI, confidence interval; HR. hazard ratio; PSM, propensity score matchingBack to article page